EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study

Abstract

Objectives and methods

The interaction between the two best documented risk factors (human leukocyte antigen [HLA] class II [DRB1*1501 positivity] and Epstein-Barr virus [elevated Epstein-Barr nuclear antigen 1 (EBNA-1) antibody reactivity]) for multiple sclerosis (MS) was studied in a case-control study of biobank samples from 109 MS cases and 212 matched referents.

Results

Multivariate logistic regression analysis showed that both were statistically significant in both sexes. HLA DRB1*1501-positive referents had higher EBNA-1 reactivity than HLA-negative referents. Less EBNA-1 reactivity was required to increase the MS risk in HLA DRB1*1501-positives than in HLA-negatives.

Conclusion

We suggest that HLA DRB1*1501-positive individuals have an increased vulnerability to EBV-induced autoimmunity.

Keywords

EBNA-1 epstein-barr virus HLA DRB1*1501 multiple sclerosis

Get full access to this article

View all access options for this article.

References

1 Schmidt H Williamson D Ashley-Koch A . HLA-DR15 haplotype and multiple sclerosis: a Huge review. Am J Epidemiol 2007; 165: 1097–1109.

2 Ramagopalan SV Morris AP Dyment DA . The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007; 3: 1607–1613.

3 Sumaya CV Myers LW Ellison GW . Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 1980; 37: 94–96.

4 Ascherio A Munger KL Lennette ET . Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286: 3083–3088.

5 Sundstrom P Juto P Wadell G . An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004; 62: 2277–2282.

6 Sundstrom P Nystrom L Forsgren L . Incidence (1988–97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 2003; 74: 29–32.

7 Olerup O Aldener A Fogdell A . HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119–134.

8 Nielsen TR Rostgaard K Nielsen NM . Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64: 72–75.

9 Serafini B Rosicarelli B Franciotta D . Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899–2912.

10.

10 Sharipo A Imreh M Leonchiks A Imreh S Masucci MG . A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat Med 1998; 4: 939–944.